According to sources, many health workers in the JJ hospital have raised safety concerns over administering the vaccine for the coronavirus, Covaxin.
Earlier on January 3, the Drug Controller General of India (DCGI) Dr VG Somani announced that the vaccines of Serum Institue of India, Covishield, and Bharat Biotech, Covaxin, have been granted permission for restricted use in an emergency situation.
As per reports, Mumbai's JJ hospital received very little response on Tuesday, January 19. The hospital is the only centre in the city for the Covaxin vaccination. About 100 people were expected to be vaccinated on Tuesday, however, only 13 of the health workers came for the vaccination.
In phase one and phase two clinical trials, Covaxin has demonstrated the ability to produce antibodies against the coronavirus. However, the clinical efficacy of Covaxin is yet to be established and it is still being studied in phase three clinical trial.
Meanwhile, the COVID-19 vaccination drive will be resumed at 285 centres in the state on Tuesday. Moreover, around 4,000 people will be vaccinated on daily basis in Mumbai Municipal Corporation areas.
On the other hand, in recent developments, two people have been admitted to a hospital in Mumbai after vaccination. One person had low blood pressure and the other had other problems. Both have been admitted to the hospital and their condition is now said to be stable. In addition, more than 200 minor complaints have been received. These include fever, body aches and simple acne. However, so far, no one has been seriously affected.
Share
Tweet
